Results 131 to 140 of about 212,093 (280)
Cost Effectiveness and Resource AllocationObjectives The population of older adults continues to grow in Iran, with pharmaceutical costs as a leading driver of household health-related costs.
Mehran Faraji +6 more
doaj +1 more source
A Deep Learning Framework for Forecasting Medium‐Term Covariance in Multiasset Portfolios
Journal of Forecasting, EarlyView.ABSTRACT Forecasting the covariance matrix of asset returns is central to portfolio construction, risk management, and asset pricing. However, most existing models struggle at medium‐term horizons, several weeks to months, where shifting market regimes and slower dynamics prevail.
Pedro Reis, Ana Paula Serra, João Gama
wiley +1 more source
Imitation of location choices for rare foreign ventures: Tax‐motivated relocations of headquarters
Global Strategy Journal, EarlyView.Abstract Research Summary Peer firms tend to imitate each other's location choices for foreign subsidiaries. We examine whether they also engage in location choice imitation when undertaking rare, high‐stakes foreign ventures in the form of tax‐motivated relocations of headquarters.
Aleksi Eerola +2 more
wiley +1 more source
Pharmaceutical policy and health economics
Folia Pharmacologica Japonica, 2013 Hiroaki, Kakihara +2 more
openaire +3 more sources
Product cycles, innovation and exports: A study of Indian pharmaceuticals [PDF]
This paper sheds light on the product cycle and neotechnology theories of trade in the context of generic pharmaceuticals. The paper studies the export performance of 177 Indian pharmaceutical firms for the post- liberalization period 1991-2004.
Alka Chadha
core
Health Economics, EarlyView.ABSTRACT In France, the Couverture Maladie Universelle Complémentaire (CMU‐C) scheme is a means‐tested, state‐financed, complementary health insurance program that fully covers healthcare. Using administrative claims data and a staggered difference‐in‐differences approach, we estimate the impact of enrollment in the program on healthcare utilization ...
Benoît Carré +2 more
wiley +1 more source
The Effect of Voluntary Staying at Home on Japanese Female Suicide During the COVID‐19 Pandemic
Health Economics, EarlyView.ABSTRACT In Japan, female suicide increased during the COVID‐19 pandemic. This study evaluated how pandemic‐related home confinement affected female suicide. We employed a shift‐share instrumental variable design to assess whether differential exposure to the pandemic caused changes in suicide incidence.
Yoko Ibuka +3 more
wiley +1 more source
Price regulation and generic competition in the pharmaceutical market [PDF]
In March 2003 the Norwegian government implemented yardstick based price regulation schemes on a selection of drugs experiencing generic competition. The retail price cap, termed “index price”, on a drug (chemical substance) was set equal to the average ...
Dalen, Dag Morten +2 more
core
Medicare Part D and Hospital Admissions due to Antimicrobial Resistance
Health Economics, EarlyView.ABSTRACT Antimicrobial resistance (AMR) has been increasing rapidly in the United States despite government efforts to contain its spread. Both under‐utilization and overuse of prescribed antimicrobials contribute to rising resistance. The introduction of Medicare Part D in 2006 expanded prescription drug coverage for the elderly, including coverage ...
Ricardo B. Ang III
wiley +1 more source
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal [PDF]
The poorest nations of the world suffer from extreme disease burdens, which go largely untreated because weak incomes and the prevailing system of intellectual property rights fail to provide sufficient incentives to develop new treatments and distribute
Ganslandt, Mattias +2 more
core